Evidence map›Paper›PMID 30104768›Full record

ArticleNature medicine2018

Clinically applicable deep learning for diagnosis and referral in retinal disease.

Jeffrey De Fauw, Joseph R Ledsam, Bernardino Romera-Paredes, Stanislav Nikolov, Nenad Tomasev, Sam Blackwell, Harry Askham, Xavier Glorot, Brendan O'Donoghue, Daniel Visentin and 24 more

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 907 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
907citing papers in PubMed, 4 pooled it
210.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05747144 unknown statusnot on this mapstarted 2021, after this paper: background citation

Multimodal Imaging in Vitreo-retinal Surgery and Macular Dystrophies: Biomarkers of Morpho-Functional Recovery by Artificial Intelligence

TypeobservationalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2021 to 2025Enrolled100ConditionsMacular Holes, Epiretinal Membrane, Retinal Detachment, Macular DystrophiesArmsBiometry, Retinography (Color) + Autofluorescence (AF), OCT B-scan and OCT angiography (OCTA), Microperimetry, Electrophysiological exams
NCT07497815 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Development and Validation of an Artificial Intelligence-assisted Diagnostic System for Ophthalmic Pathologies

TypeobservationalSponsorMarisse Masis-SolanoRan2026 to 2029Enrolled15,000ConditionsMacular Degeneration, Diabetic Retinopathy (DR), Glaucoma, KeratoconusArmsNo interventions
3 · Its place in the literature

Who cites it

907 citing papers in PubMed, 4 syntheses or guidelines pooled it, 2,512 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Artificial intelligence for glaucoma.The Cochrane database of systematic reviews · 2025
    Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Current Trends in AI and Eye Disease Diagnostics.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Artificial intelligence in diabetic retinopathy: from automated screening to risk-stratified care.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  19. Article
  20. Article

847 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 3 institutions in 1 country.

Jeffrey De FauwDeepMind, London, UK.
Joseph R LedsamDeepMind, London, UK.
Bernardino Romera-ParedesDeepMind, London, UK.
Stanislav NikolovDeepMind, London, UK.
Nenad TomasevDeepMind, London, UK.
Sam BlackwellDeepMind, London, UK.
Harry AskhamDeepMind, London, UK.
Xavier GlorotDeepMind, London, UK.
Brendan O'DonoghueDeepMind, London, UK.
Daniel VisentinDeepMind, London, UK.
George van den DriesscheDeepMind, London, UK.
Balaji LakshminarayananDeepMind, London, UK.
Clemens MeyerDeepMind, London, UK.
Faith MackinderDeepMind, London, UK.
Simon BoutonDeepMind, London, UK.
Kareem AyoubDeepMind, London, UK.
Reena ChopraNIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.ORCID http://orcid.org/0000-0002-4264-8329
Dominic KingDeepMind, London, UK.
Alan KarthikesalingamDeepMind, London, UK.
Cían O HughesDeepMind, London, UK.ORCID http://orcid.org/0000-0001-6901-0985
Rosalind RaineUniversity College London, London, UK.
Julian HughesNIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
Dawn A SimNIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
Catherine EganNIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
Adnan TufailNIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
Hugh MontgomeryUniversity College London, London, UK.ORCID http://orcid.org/0000-0001-8797-5019
Demis HassabisDeepMind, London, UK.
Geraint ReesUniversity College London, London, UK.ORCID http://orcid.org/0000-0002-9623-7007
Trevor BackDeepMind, London, UK.
Peng T KhawNIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
Mustafa SuleymanDeepMind, London, UK.
Julien CornebiseDeepMind, London, UK.
Pearse A KeaneNIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK. pearse.keane@moorfields.nhs.uk.ORCID http://orcid.org/0000-0002-9239-745X
Olaf RonnebergerDeepMind, London, UK. olafr@deepmind.com.ORCID http://orcid.org/0000-0002-4266-1515
Google DeepMind (United Kingdom) · GBMoorfields Eye Hospital · GBUniversity College London · GB

Funding

Department of Health CS-2014-14-023
6 · The paper itself

Abstract

The volume and complexity of diagnostic imaging is increasing at a pace faster than the availability of human expertise to interpret it. Artificial intelligence has shown great promise in classifying two-dimensional photographs of some common diseases and typically relies on databases of millions of annotated images. Until now, the challenge of reaching the performance of expert clinicians in a real-world clinical pathway with three-dimensional diagnostic scans has remained unsolved. Here, we apply a novel deep learning architecture to a clinically heterogeneous set of three-dimensional optical coherence tomography scans from patients referred to a major eye hospital. We demonstrate performance in making a referral recommendation that reaches or exceeds that of experts on a range of sight-threatening retinal diseases after training on only 14,884 scans. Moreover, we demonstrate that the tissue segmentations produced by our architecture act as a device-independent representation; referral accuracy is maintained when using tissue segmentations from a different type of device. Our work removes previous barriers to wider clinical use without prohibitive training data requirements across multiple pathologies in a real-world setting.

Indexed as

Deep LearningReferral and ConsultationAgedClinical Decision-MakingFemaleHumansMaleMiddle AgedRetinaRetinal DiseasesTomography, Optical Coherence

Identifiers

PMID30104768
OpenAlexW2886281300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.